Fitch Reaffirms Australia's AAA Credit Rating
Fitch, an international ratings agency, has reaffirmed Australia's AAA credit rating, citing the country's strong economic fundamentals and responsible economic management.
BUSINESS NEWS
Search Business News
Find articles by title or summary.
For businessesCreate a free company profile →
European Medicines Agency Approves Pfizer's COVID-19 Treatment for Children Under 5
The European Medicines Agency (EMA) has approved Pfizer's COVID-19 treatment, Paxlovid, for children under 5 years old, marking a significant milestone in the fight against the pandemic
European Medicines Agency Approves Pfizer's COVID-19 Vaccine Booster for Children Under 5
The European Medicines Agency (EMA) has approved Pfizer's COVID-19 vaccine booster for children under 5 years old, marking a significant milestone in the fight against the pandemic
European Medicines Agency Approves Modification to Paediatric Investigation Plan for Fabhalta and Iptacopan
The European Medicines Agency has made a decision on a modification to a Paediatric Investigation Plan (PIP) for Fabhalta and Iptacopan, a treatment for Renal and urinary disorders, following an application for change to the existing plan.
European Medicines Agency Approves Modification to Paediatric Investigation Plan for Inaqovi, a Treatment for Blood and Lymphatic System Disorders
The European Medicines Agency has issued an opinion and decision on a modification to the Paediatric Investigation Plan (PIP) for Inaqovi, a treatment for blood and lymphatic system disorders, as requested by the manufacturer.
Winners of the 2026 EEA "Resilient by Nature" photo competition announced
A bird navigating trash in a drainage pipe to the nature's ability to recover after a forest fire these are just two of the winning photos announced today that captured the spirit and ethos of this year's European...
Winners of the 2026 EEA "Resilient by Nature" photo competition announced
A bird navigating trash in a drainage pipe to nature's ability to recover after a forest fire these are just two of the winning photos announced today that captured the spirit and ethos of this year's European Environment...
European Medicines Agency Proposes Enhanced Evaluation of COVID-19 Vaccines
The European Medicines Agency (EMA) has issued a new proposal for the evaluation of COVID-19 vaccines, following recent concerns over their effectiveness in certain populations. The proposal aims to improve the assessment of vaccine efficacy and safety, and is expected to be discussed by the EMA's Committee for Medicinal Products for Human Use (CHMP) in the coming months.
European Medicines Agency Approves Modification to Paediatric Investigation Plan for Agamree and Vamorolone
The European Medicines Agency has made a decision on a modification to the Paediatric Investigation Plan (PIP) for Agamree and vamorolone, a treatment for congenital, familial, and genetic disorders, following an application for change to the existing plan.
European Medicines Agency Approves Pfizer's COVID-19 Vaccine Booster for Children Under 5
The European Medicines Agency (EMA) has approved Pfizer's COVID-19 vaccine booster for children under 5 years old, marking a significant development in the fight against the pandemic
Amendment to "Price of Eligible Collateral"
Amendment to the "Price of Eligible Collateral".
European Medicines Agency Approves Modification to Paediatric Investigation Plan for Emgality and Galcanezumab
The European Medicines Agency has issued an opinion and decision on a Paediatric Investigation Plan (PIP) for Emgality and Galcanezumab, a modification to an agreed PIP for surgical and medical procedures, following a request from the applicant.
Amendment to "Prices of Eligible Collateral"
The Federal Reserve has announced an amendment to its "Prices of Eligible Collateral" policy, which will take effect on January 1, 2024. The updated policy aims to improve the efficiency of the Federal Reserve's collateral management process.
European Medicines Agency Approves Modification to Paediatric Investigation Plan for Nilemdo
The European Medicines Agency (EMA) has made a decision on a modification to a Paediatric Investigation Plan (PIP) for Nilemdo, a medication containing bempedoic acid (ETC-1002), which is used to treat metabolism and nutrition disorders. The decision was made in response to a request from the manufacturer to modify the original PIP.
Singapore Prepares to Enhance Haze Response Efforts
The Singapore government is taking proactive measures to bolster its response to haze, a persistent air pollution issue affecting the region, following recent concerns and recommendations from various stakeholders, including the National Environment Agency and the Committee on the Environment and Climate Change.
European Medicines Agency Approves Pfizer's COVID-19 Vaccine Booster for Children Under 5
The European Medicines Agency (EMA) has approved Pfizer's COVID-19 vaccine booster for children under 5 years old, marking a significant milestone in the fight against the pandemic
European Medicines Agency Approves Modification to Paediatric Investigation Plan for Aimovig and Erenumab
The European Medicines Agency has issued an opinion and decision on a Paediatric Investigation Plan (PIP) for Aimovig and Erenumab, a therapeutic area of surgical and medical procedures, following a modification application to the agreed PIP.
European Medicines Agency Approves Pfizer's COVID-19 Vaccine Booster for Children Under 5
The European Medicines Agency (EMA) has approved Pfizer's COVID-19 vaccine booster for children under 5 years old, marking a significant milestone in the fight against the pandemic
European Medicines Agency Approves Pfizer's COVID-19 Vaccine Booster for Children Under 5
The European Medicines Agency (EMA) has approved Pfizer's COVID-19 vaccine booster for children under 5 years old, marking a significant milestone in the fight against the pandemic
European Medicines Agency Approves Modification to Paediatric Investigation Plan for Enerzair Breezhaler
The European Medicines Agency has issued an opinion and decision on a modification to the Paediatric Investigation Plan for Enerzair Breezhaler, a respiratory medication, following a request from the manufacturer to update the plan.
Haze Situation Update
The Singapore government has scheduled a meeting with the National Environment Agency (NEA) and the Public Utilities Board (PUB) to discuss the ongoing haze situation in the country, which has been recently exacerbated by forest fires in Indonesia. The committee will review the current air quality index and propose measures to mitigate the effects of the haze on the public health.
FSB Report Assesses Jurisdictions on Public Sector Backstops
A recent report by the Financial Stability Board found that few jurisdictions have a public sector backstop in place to meet the funding needs of large systemic banks in resolution or failure.
Austria Launches School for Radiation Emergency Management
The Austrian government has established a school to train professionals in managing radiation emergencies, following a proposal by the Ministry of Health, and is scheduled to open in 2024, with the first class expected to start recently.
Phosphate Fertilizers From Morocco and Russia; Scheduling of Full Five-Year Reviews
The U.S. Commission has scheduled full reviews to determine whether to revoke countervailing duty orders on phosphate fertilizers from Morocco and Russia, as per the Tariff Act of 1930.
Certain Dynamic Random Access Memory (DRAM) Devices, Products Containing the Same, and Components Thereof; Notice of Commission Determination Not To Review an Initial Determination Terminating the Investigation Based on Settlement; Termination of the Investigation
The U.S. International Trade Commission has decided not to review an initial determination to terminate an investigation into DRAM devices and products based on a settlement.
Certain Hydrodermabrasion Systems and Components Thereof; Notice of Vacatur of the Commission's Final Determination and Mootness of the Investigation by the Federal Circuit Due to Patent Expiration
The U.S. Court of Appeals for the Federal Circuit has vacated the U.S. International Trade Commission's final determination in the Certain Hydrodermabrasion Systems and Components Thereof investigation due to patent expiration.
Advisory Committee on the Medical Uses of Isotopes: Meeting Notice
The U.S. Nuclear Regulatory Commission will convene a virtual meeting of the Advisory Committee on the Medical Uses of Isotopes on October 26-27, 2026, to discuss agenda items.
Fermi America LLC (dba Fermi America); Project Matador Advanced Energy and Intelligence Campus AP1000 Units 1-4; Project Matador Nuclear Units 1-4; Draft Environmental Impact Statement
The U.S. Nuclear Regulatory Commission (NRC) is issuing a draft Environmental Impact Statement (EIS) for public comment in response to a Combined License (COL) application submitted by Fermi America LLC.
NCUA Approves Proposal to Revise NCUA Call Report (Form 5300) for Public Comment
The National Credit Union Administration (NCUA) has approved the publication of a proposal to revise the NCUA Call Report (Form 5300) for public comment, including the collection of new data.
Air Plan Approval; Michigan; Clean Data Determination for the Berrien, MI and Muskegon, MI Areas for the 2015 Ozone Standards
The U.S. Environmental Protection Agency (EPA) is determining under the Clean Air Act (CAA) that the Berrien County and Muskegon County, Michigan nonattainment areas have attained the 2015 ozone National Ambient Air Quality Standards.
Environmental Impact Statements; Notice of Availability
The U.S. Environmental Protection Agency (EPA) has made available Environmental Impact Statements for various projects.
Schedules of Controlled Substances: Placement of O-Desmethyltramadol in Schedule I; Correction
The Drug Enforcement Administration published a temporary order placing O-desmethyltramadol in Schedule I on August 12, 2026, correcting a previous action.
Vladimir Romaniv, P.A.; Decision and Order
The summary is not available as the source is an automatically generated message.
L Krenk DBA Maui Clinic Pharmacy; Decision and Order
No summary available, as the provided source only contains a title and an automated message.
Alexandra R. Lovec, A.P.R.N.; Decision and Order
Automatically collected message from the source.
Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products
The Drug Enforcement Administration (DEA) is revoking the exempted status for certain nonnarcotic prescription products that are currently on DEA's Table of Exempted Prescription Products, due to inactive National Drug Codes.
Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof
The National Institute of Allergy and Infectious Diseases is contemplating the grant of an exclusive, sublicensable patent license for an antibody specifically binding to Severe Fever With Thrombocytopenia Syndrome Virus antigen and its use.
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
The National Institute of Allergy and Infectious Diseases has announced a closed meeting, but details about the meeting are not provided in the notice.
Food and Drug Administration Announces Public Meeting on Lot-Level Food Traceability
The Food and Drug Administration is hosting a public meeting to discuss challenges and solutions in lot-level food traceability.
Requirements for Additional Traceability Records for Certain Foods: Enforcement Policy for Certain Retail Food Establishments and Restaurants; Draft Guidance for Industry; Availability
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry titled 'Requirements for Additional Traceability Records for Certain Foods: Enforcement Policy for Certain Retail Food Establishments and Restaurants'.
Agency Information Collection Activities: Proposed Collection; Comment Request
The U.S. Department of the Treasury is seeking public comments on a proposed information collection activity related to the reporting of certain financial transactions.
Medical Devices; Immunology and Microbiology Devices; Classification of the Hematopoietic Cell Enrichment Kit
The FDA is classifying the hematopoietic cell enrichment kit into class II (special controls) with identified special controls for the device type.
Classification of the Infant Pulse Rate and Oxygen Saturation Monitor for Over-the-Counter Use
The FDA is classifying the infant pulse rate and oxygen saturation monitor for over-the-counter use into class II, with special controls.
Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens
The US Food and Drug Administration (FDA) is classifying a system for detecting nucleic acid from non-viral microorganisms causing sexually transmitted infections using home-collected specimens into Class II.
Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications; Correction
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register on June 3, 2026, regarding the withdrawal of approval of 16 abbreviated new drug applications (ANDAs) filed by Elite Laboratories, Inc. and other companies.
Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Applicant Organizational National Provider Identifiers and Centers for Medicare & Medicaid Services Certification Numbers Form
HRSA submitted an Information Collection Request to the Office of Management and Budget for review and approval, in compliance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Data System for Organ Procurement and Transplantation Network, OMB No. 0906-0110-Revision
HRSA submitted an Information Collection Request to the Office of Management and Budget for review and approval of the Data System for Organ Procurement and Transplantation Network.
Withdrawal of Approval of Abbreviated New Drug Application for Celecoxib Capsules, 50 Milligrams, 100 Milligrams, 200 Milligrams, and 400 Milligrams
The US FDA is withdrawing approval of Amneal Pharmaceuticals' abbreviated new drug application (ANDA) 208833 for Celecoxib capsules in various strengths.
Par Health USA LLC, U.S. Agent for PH Health Limited, et al.; Withdrawal of Approval of 37 Abbreviated New Drug Applications
The FDA is withdrawing approval of 37 abbreviated new drug applications from multiple applicants, following written notifications from the applicants.
Determination That LASIX (Furosemide) Oral Solution, 10 Milligrams/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The US Food and Drug Administration (FDA) has determined that LASIX (furosemide) oral solution, 10 milligrams/milliliter, was not withdrawn from sale for reasons of safety or effectiveness.